Part,  Chapter, Paragraph

 1    I,     2. 11    |             2007): Nanoparticles: pharmacological and toxicological significance.
 2   II,     5.  1.  3|       other interventions such as pharmacological and physical therapy .~ ~
 3   II,     5.  2.  5|   appropriate target, a life-long pharmacological treatment with drugs must
 4   II,     5.  2.  6|     patient considered is high, a pharmacological treatment should be considered.
 5   II,     5.  2.  6|     taking into consideration the pharmacological differences among these
 6   II,     5.  5.  3|        for psychotherapeutic than pharmacological treatments (Lehman et al,
 7   II,     5.  5.  3|           Middelboe, 2001).~While pharmacological treatments are extensively
 8   II,     5.  5.  3|        and despite the variety of pharmacological and surgical treatment options
 9   II,     5. 10.  1|           on enzyme deficiencies, pharmacological reactions or, most frequently,
10  III,    10.  2.  1| Individual interventions, such as pharmacological and behavioural therapies
11  III,    10.  2.  1|     behavioural, psychosocial and pharmacological interventions of varying
12  III,    10.  2.  3|         of the patient is high, a pharmacological treatment must be considered.
13   IV,    11.  4    |         to diagnostic procedures, pharmacological and non-pharmacological
14   IV,    12.  2    |   appropriate target, a life-long pharmacological treatment with drugs must
15   IV,    12.  2    |    behavioural, psychosocial, and pharmacological interventions of varying